Nu-Med Plus (NUMD) Net Income Growth (3y) (2015 - 2025)
Nu-Med Plus (NUMD) Net Income Growth (3y) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.26 Bn | 175.96 Bn | 6.27 Bn | -6.51% |
| 2 | Stryker | 128.79 Bn | 125.92 Bn | 3.81 Bn | 7.96% |
| 3 | Medtronic | 108.56 Bn | 99.34 Bn | 6.41 Bn | 1.93% |
| 4 | Boston Scientific | 68.31 Bn | 66.86 Bn | 3.61 Bn | 62.29% |
| 5 | Edwards Lifesciences | 47.27 Bn | 43.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.42 Bn | 27.31 Bn | 750.30 Mn | 60.12% |
| 7 | GE HealthCare Technologies | 28.40 Bn | 26.12 Bn | 1.98 Bn | 2.38% |
| 8 | Smith & Nephew | 26.95 Bn | 26.37 Bn | - | - |
| 9 | Koninklijke Philips | 25.52 Bn | 22.40 Bn | 2.07 Bn | 280.49% |
| 10 | Nu-Med Plus | 1.67 Mn | 1.67 Mn | - | -31.93% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -31.93% |
| Sep 30, 2025 | 40.93% |
| Jun 30, 2025 | 41.43% |
| Mar 31, 2025 | 30.61% |
| Dec 31, 2024 | 83.10% |
| Sep 30, 2024 | 45.96% |
| Jun 30, 2024 | 59.06% |
| Mar 31, 2024 | 60.60% |
| Dec 31, 2023 | 51.87% |
| Sep 30, 2023 | 66.93% |
| Jun 30, 2023 | 70.09% |
| Mar 31, 2023 | 43.62% |
| Dec 31, 2022 | 29.62% |
| Sep 30, 2022 | 27.22% |
| Jun 30, 2022 | 37.63% |
| Mar 31, 2022 | 48.34% |
| Dec 31, 2021 | -90.92% |
| Sep 30, 2021 | 38.84% |
| Jun 30, 2021 | -15.42% |
| Mar 31, 2021 | -37.39% |